Cognetivity Neurosciences (XCNQ:CGN) Net Income From Continuing Operations : C$-8.64 Mil (TTM As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Cognetivity Neurosciences's net income from continuing operations for the three months ended in Oct. 2023 was C$-2.04 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Oct. 2023 was C$-8.64 Mil.

Cognetivity Neurosciences Net Income From Continuing Operations Historical Data

The historical data trend for Cognetivity Neurosciences's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Net Income From Continuing Operations Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-4.19

-2.65

-1.93

-13.13

-7.43

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-1.80	-2.56	-2.11	-1.94	-2.04

Cognetivity Neurosciences Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-8.64 Mil.

Cognetivity Neurosciences (XCNQ:CGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

CGNSF:USA 1UB:Germany

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Executives

Ravinder Kang

Director

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines